Cite
HARVARD Citation
Wagner, N. et al. (2021). Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. Journal for immunotherapy of cancer. 9 (5), p. . [Online].